organic compounds
of ethyl 2,4-dichloroquinoline-3-carboxylate
aCentro de Graduados e Investigación en Química del Instituto, Tecnológico de, Tijuana, Apdo. Postal 1166, 22500, Tijuana, B.C., Mexico, and bInstituto de Química, Universidad Nacional Autónoma de, México, Circuito, Exterior, S. N., Ciudad Universitaria, Coyoacán, México, D. F. 04510, Mexico
*Correspondence e-mail: dchavez@tectijuana.mx
In the 12H9Cl2NO2, the mean planes through the quinoline and carboxylate groups have r.m.s. deviations of 0.006 and 0.021 Å, respectively, and form a dihedral angle of 87.06 (19)°. In the crystal, molecules are linked via very weak C—H⋯O hydrogen bonds, forming chains, which propagate along the c-axis direction.
of the title compound, CCCDC reference: 1434378
1. Related literature
For the potential of related compounds in anti-HIV treatment, see: Maartens et al. (2014); Hopkins et al. (2004). For a related structure, see: Reyes et al. (2013)
2. Experimental
2.1. Crystal data
|
2.2. Data collection
|
2.3. Refinement
|
Data collection: APEX2 (Bruker, 2012); cell SAINT (Bruker, 2012); data reduction: SAINT; program(s) used to solve structure: SHELXTL (Sheldrick, 2015); program(s) used to refine structure: SHELXL2013 (Sheldrick, 2015); molecular graphics: SHELXTL; software used to prepare material for publication: SHELXTL.
Supporting information
CCDC reference: 1434378
https://doi.org/10.1107/S2056989015020587/nk2231sup1.cif
contains datablocks I, global. DOI:Structure factors: contains datablock I. DOI: https://doi.org/10.1107/S2056989015020587/nk2231Isup2.hkl
Supporting information file. DOI: https://doi.org/10.1107/S2056989015020587/nk2231Isup3.cml
The HIV (human immunodeficiency virus) is responsible of the acquired immunodeficiency syndrome (AIDS). The actual treatment consists of a group of several drugs known as anti-retrovirals which inhibit important proteins for virus replication, including reverse transcriptase (Maartens et al., 2014).
As part of the synthesis of promising compounds as anti-retrovirals, Stammers and coworkers, maintaining as base structure a quinolone core, found compounds that showed activity in the inhibition of the reverse transcriptase. They obtained a dibromide quinolone in C2/C4 as an intermediate. After that, they were able to remove the C2 bromine in an acetic acid solution and finally, the C4 bromine was substituted by alkyl-sulfurated compounds to get the final molecules which have been proven activity against HIV (Hopkins et al., 2004),
As part of our ongoing research, we have synthesized different pyridin-2 (1H)-one analogues (Reyes et al., 2013). In this work, we developed a methodology to obtain derivatives of quinolone, with saturated and unsaturated
in in C4 with ethyl 4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxilate as a starting material. Chlorination of the quinolone core results in the dichlorinated compound ethyl 2,4-dichloroquinoline-3-carboxylate with a yield of 70% and a was obtained. The intermediate of interest, the ethyl 4-chloro-2-oxo-1,2-dihydroquinoline-3-carboxylate, was obtained after treatment of the dichlorinated compound with an acetic acid solution following the methodology described by Stammers (Hopkins et al., 2004) in >98% yield (see experimental section in supplementary material).The structure of the compound is shown in Fig. 1. The two aromatic rings of quinoline are fused almost coaxially, with a dihedral angle between their planes of C8—C9—C10—C4= 179.21 (14)o. The carboxylate group is in an antiperiplanar conformation to the quinoline with a torsion angle C12—O2—C11—C3 = -179.39 (15)°, and bonded to the quinoline over the plane C3—C11—O2 by 110.46 (14)o. The deviation of the bond length values for C2—Cl1= 1.745 (2) and C4— Cl 2= 1.7248 (16) from the standard values can be attributed for the sp2
of the quinoline ring. In the crystal, molecules are linked via O1—H7 intermolecular hydrogen bonds forming chains propagating along the c axis direction. (Fig. 2).The synthesis of ethyl 2,4-dichloroquinoline-3-carboxylate and ethyl 4-chloro-2-oxo-1,2-dihydroquinoline-3-carboxylate includes reagents and reagent grade solvents, which were used without further purification. In a 100 mL round bottom flask equipped with a magnetic stirrer was placed 500 mg of ethyl 4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxylate (2.15 mmol) and 1.96 g of benzyltriethylammonium chloride in 15 mL of acetonitrile. Under continuous stirring, 0.88 mL of the phosphoryl chloride (9.46 mmol) was added drop by drop. The mixture was stirred at 40o C for 30 min and later at reflux for 1 h. Then, the solvent was evaporated and 15 mL of cold water was added and stirred for 1 h. Then a precipitate was obtained corresponding to a mixture of ethyl 2,4-dichloroquinoline-3-carboxylate and ethyl 4-chloro-2-oxo-1,2-dihydroquinoline-3-carboxylate. The precipitate was dissolved in 3 mL of dichloromethane-methanol (1:1, v/v). Partial evaporation leads to crystals (not suitable for X-ray diffraction) of ethyl 4-chloro-2-oxo-1,2-dihydroquinoline-3-carboxylate (0.65 mmol, 30%). The rest corresponded to ethyl 2,4-dichloroquinoline-3-carboxylate (1.5 mmol, 70%). The latter compound was placed in a round bottom flask of 50 mL containing acetic acid (10 mL) and water (5 mL). The mixture was stirred under reflux for 24 h. After cooling, the product was extracted with ethyl ether to afford ethyl 4-chloro-2-oxo-1,2-dihydroquinoline-3-carboxylate (>98%).
Ethyl 2,4-dichloroquinoline-3-carboxylate: m.p. 83-85 °C. 1H RMN (DMSO-d6): δ 8.27 (dd, J = 8.3, 0.6 Hz, H-5), 8.09 (dd, J = 8.3, 0.6 Hz, H-8), 8.03 (ddd, J = 7.7, 6.9, 1.4 Hz, H-7), 7.89 (ddd, J = 7.7, 6.9, 1.4 Hz, H-6) 4.51 (q, J = 7.1 Hz, COOCH2CH3), 1.39 (t, J = 7.1 Hz, COOCH2CH3). 13C RMN (DMSO-d6): δ 163.5, 147.2, 144.7, 141.1, 133.7, 130.2, 129.1, 127.1, 124.9, 124.3, 63.4, 14.3. IEMS m/e (int. rel): [M]+ 269 (32), [M]++2 271 (21), [M]++4 273 (3), 241 (26), 223 (100), 195 (17), 161 (28) amu.
Crystals of the title compound suitable for X-ray diffraction were obtained by dissolving 15 mg of ethyl 2,4-dichloroquinoline-3-carboxylate in 0.5 mL of ethanol-di-ethyl ether (1:1, v / v) and placing the solution in a glass vial. The solution was allowed to stand at room temperature for 7 days and the crystals formed were filtered.
The HIV (human immunodeficiency virus) is responsible of the acquired immunodeficiency syndrome (AIDS). The actual treatment consists of a group of several drugs known as anti-retrovirals which inhibit important proteins for virus replication, including reverse transcriptase (Maartens et al., 2014).
As part of the synthesis of promising compounds as anti-retrovirals, Stammers and coworkers, maintaining as base structure a quinolone core, found compounds that showed activity in the inhibition of the reverse transcriptase. They obtained a dibromide quinolone in C2/C4 as an intermediate. After that, they were able to remove the C2 bromine in an acetic acid solution and finally, the C4 bromine was substituted by alkyl-sulfurated compounds to get the final molecules which have been proven activity against HIV (Hopkins et al., 2004),
As part of our ongoing research, we have synthesized different pyridin-2 (1H)-one analogues (Reyes et al., 2013). In this work, we developed a methodology to obtain derivatives of quinolone, with saturated and unsaturated
in in C4 with ethyl 4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxilate as a starting material. Chlorination of the quinolone core results in the dichlorinated compound ethyl 2,4-dichloroquinoline-3-carboxylate with a yield of 70% and a was obtained. The intermediate of interest, the ethyl 4-chloro-2-oxo-1,2-dihydroquinoline-3-carboxylate, was obtained after treatment of the dichlorinated compound with an acetic acid solution following the methodology described by Stammers (Hopkins et al., 2004) in >98% yield (see experimental section in supplementary material).The structure of the compound is shown in Fig. 1. The two aromatic rings of quinoline are fused almost coaxially, with a dihedral angle between their planes of C8—C9—C10—C4= 179.21 (14)o. The carboxylate group is in an antiperiplanar conformation to the quinoline with a torsion angle C12—O2—C11—C3 = -179.39 (15)°, and bonded to the quinoline over the plane C3—C11—O2 by 110.46 (14)o. The deviation of the bond length values for C2—Cl1= 1.745 (2) and C4— Cl 2= 1.7248 (16) from the standard values can be attributed for the sp2
of the quinoline ring. In the crystal, molecules are linked via O1—H7 intermolecular hydrogen bonds forming chains propagating along the c axis direction. (Fig. 2).For the potential of related compounds in anti-HIV treatment, see: Maartens et al. (2014); Hopkins et al. (2004). For a related structure, see: Reyes et al. (2013)
The synthesis of ethyl 2,4-dichloroquinoline-3-carboxylate and ethyl 4-chloro-2-oxo-1,2-dihydroquinoline-3-carboxylate includes reagents and reagent grade solvents, which were used without further purification. In a 100 mL round bottom flask equipped with a magnetic stirrer was placed 500 mg of ethyl 4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxylate (2.15 mmol) and 1.96 g of benzyltriethylammonium chloride in 15 mL of acetonitrile. Under continuous stirring, 0.88 mL of the phosphoryl chloride (9.46 mmol) was added drop by drop. The mixture was stirred at 40o C for 30 min and later at reflux for 1 h. Then, the solvent was evaporated and 15 mL of cold water was added and stirred for 1 h. Then a precipitate was obtained corresponding to a mixture of ethyl 2,4-dichloroquinoline-3-carboxylate and ethyl 4-chloro-2-oxo-1,2-dihydroquinoline-3-carboxylate. The precipitate was dissolved in 3 mL of dichloromethane-methanol (1:1, v/v). Partial evaporation leads to crystals (not suitable for X-ray diffraction) of ethyl 4-chloro-2-oxo-1,2-dihydroquinoline-3-carboxylate (0.65 mmol, 30%). The rest corresponded to ethyl 2,4-dichloroquinoline-3-carboxylate (1.5 mmol, 70%). The latter compound was placed in a round bottom flask of 50 mL containing acetic acid (10 mL) and water (5 mL). The mixture was stirred under reflux for 24 h. After cooling, the product was extracted with ethyl ether to afford ethyl 4-chloro-2-oxo-1,2-dihydroquinoline-3-carboxylate (>98%).
Ethyl 2,4-dichloroquinoline-3-carboxylate: m.p. 83-85 °C. 1H RMN (DMSO-d6): δ 8.27 (dd, J = 8.3, 0.6 Hz, H-5), 8.09 (dd, J = 8.3, 0.6 Hz, H-8), 8.03 (ddd, J = 7.7, 6.9, 1.4 Hz, H-7), 7.89 (ddd, J = 7.7, 6.9, 1.4 Hz, H-6) 4.51 (q, J = 7.1 Hz, COOCH2CH3), 1.39 (t, J = 7.1 Hz, COOCH2CH3). 13C RMN (DMSO-d6): δ 163.5, 147.2, 144.7, 141.1, 133.7, 130.2, 129.1, 127.1, 124.9, 124.3, 63.4, 14.3. IEMS m/e (int. rel): [M]+ 269 (32), [M]++2 271 (21), [M]++4 273 (3), 241 (26), 223 (100), 195 (17), 161 (28) amu.
Crystals of the title compound suitable for X-ray diffraction were obtained by dissolving 15 mg of ethyl 2,4-dichloroquinoline-3-carboxylate in 0.5 mL of ethanol-di-ethyl ether (1:1, v / v) and placing the solution in a glass vial. The solution was allowed to stand at room temperature for 7 days and the crystals formed were filtered.
detailsThe C-bound H atoms were positioned geometrically and refined using a riding model with d(C—H) = 1.00 Å, Uiso = 1.2Ueq(C) for Csp3—H, d(C—H) = 0.99 Å, Uiso = 1.2Ueq(C) for CH2 groups, d(C—H) = 0.95 Å, Uiso = 1.2Ueq(C) for aromatic C—H.
Data collection: APEX2 (Bruker, 2012); cell
SAINT (Bruker, 2012); data reduction: SAINT (Bruker, 2012); program(s) used to solve structure: SHELXTL (Sheldrick, 2015); program(s) used to refine structure: SHELXL2013 (Sheldrick, 2015); molecular graphics: SHELXTL (Sheldrick, 2015); software used to prepare material for publication: SHELXTL (Sheldrick, 2015).C12H9Cl2NO2 | F(000) = 552 |
Mr = 270.10 | Dx = 1.496 Mg m−3 |
Monoclinic, P21/c | Mo Kα radiation, λ = 0.71073 Å |
a = 8.5860 (4) Å | Cell parameters from 4843 reflections |
b = 19.9082 (11) Å | θ = 2.4–25.4° |
c = 7.1304 (4) Å | µ = 0.53 mm−1 |
β = 100.262 (1)° | T = 298 K |
V = 1199.32 (11) Å3 | Prism, colourless |
Z = 4 | 0.50 × 0.25 × 0.16 mm |
Bruker APEXII CCD area-detector diffractometer | Rint = 0.024 |
Detector resolution: 0.83 pixels mm-1 | θmax = 25.4°, θmin = 2.1° |
ω scans | h = −10→10 |
6785 measured reflections | k = −23→23 |
2197 independent reflections | l = −8→8 |
1833 reflections with I > 2σ(I) |
Refinement on F2 | Hydrogen site location: inferred from neighbouring sites |
Least-squares matrix: full | H-atom parameters constrained |
R[F2 > 2σ(F2)] = 0.035 | w = 1/[σ2(Fo2) + (0.052P)2 + 0.1257P] where P = (Fo2 + 2Fc2)/3 |
wR(F2) = 0.094 | (Δ/σ)max = 0.001 |
S = 1.05 | Δρmax = 0.22 e Å−3 |
2197 reflections | Δρmin = −0.21 e Å−3 |
156 parameters | Extinction correction: SHELXL2013 (Sheldrick, 2015), Fc*=kFc[1+0.001xFc2λ3/sin(2θ)]-1/4 |
0 restraints | Extinction coefficient: 0.010 (2) |
C12H9Cl2NO2 | V = 1199.32 (11) Å3 |
Mr = 270.10 | Z = 4 |
Monoclinic, P21/c | Mo Kα radiation |
a = 8.5860 (4) Å | µ = 0.53 mm−1 |
b = 19.9082 (11) Å | T = 298 K |
c = 7.1304 (4) Å | 0.50 × 0.25 × 0.16 mm |
β = 100.262 (1)° |
Bruker APEXII CCD area-detector diffractometer | 1833 reflections with I > 2σ(I) |
6785 measured reflections | Rint = 0.024 |
2197 independent reflections |
R[F2 > 2σ(F2)] = 0.035 | 0 restraints |
wR(F2) = 0.094 | H-atom parameters constrained |
S = 1.05 | Δρmax = 0.22 e Å−3 |
2197 reflections | Δρmin = −0.21 e Å−3 |
156 parameters |
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes. |
x | y | z | Uiso*/Ueq | ||
Cl1 | 0.85142 (7) | 0.95554 (3) | 0.67524 (10) | 0.0847 (2) | |
Cl2 | 0.49224 (5) | 0.73357 (2) | 0.59388 (7) | 0.05637 (19) | |
O1 | 0.48324 (17) | 0.90370 (7) | 0.44065 (18) | 0.0701 (4) | |
O2 | 0.48524 (14) | 0.89699 (6) | 0.75480 (17) | 0.0565 (3) | |
N1 | 0.96891 (17) | 0.83536 (9) | 0.7101 (2) | 0.0567 (4) | |
C2 | 0.8376 (2) | 0.86809 (9) | 0.6757 (2) | 0.0514 (4) | |
C3 | 0.68405 (18) | 0.84036 (8) | 0.6379 (2) | 0.0435 (4) | |
C4 | 0.67539 (18) | 0.77181 (8) | 0.6378 (2) | 0.0415 (4) | |
C5 | 0.8137 (3) | 0.66071 (10) | 0.6754 (3) | 0.0621 (5) | |
H5 | 0.7187 | 0.6372 | 0.6505 | 0.075* | |
C6 | 0.9535 (3) | 0.62696 (13) | 0.7135 (3) | 0.0816 (7) | |
H6 | 0.9531 | 0.5802 | 0.7143 | 0.098* | |
C7 | 1.0976 (3) | 0.66121 (14) | 0.7514 (3) | 0.0838 (8) | |
H7 | 1.1918 | 0.6371 | 0.7779 | 0.101* | |
C8 | 1.1014 (2) | 0.72928 (13) | 0.7498 (3) | 0.0705 (6) | |
H8 | 1.1981 | 0.7516 | 0.7748 | 0.085* | |
C9 | 0.9593 (2) | 0.76660 (10) | 0.7105 (2) | 0.0511 (5) | |
C10 | 0.81366 (19) | 0.73162 (9) | 0.6738 (2) | 0.0451 (4) | |
C11 | 0.5396 (2) | 0.88399 (9) | 0.5963 (2) | 0.0478 (4) | |
C12 | 0.3434 (2) | 0.93853 (11) | 0.7367 (3) | 0.0674 (5) | |
H12A | 0.2575 | 0.9182 | 0.6481 | 0.081* | |
H12B | 0.3638 | 0.9828 | 0.6897 | 0.081* | |
C13 | 0.3010 (3) | 0.94358 (13) | 0.9279 (3) | 0.0858 (7) | |
H13A | 0.2721 | 0.9000 | 0.9681 | 0.129* | |
H13B | 0.2133 | 0.9738 | 0.9235 | 0.129* | |
H13C | 0.3900 | 0.9602 | 1.0166 | 0.129* |
U11 | U22 | U33 | U12 | U13 | U23 | |
Cl1 | 0.0773 (4) | 0.0613 (3) | 0.1107 (5) | −0.0197 (3) | 0.0034 (3) | −0.0015 (3) |
Cl2 | 0.0445 (3) | 0.0641 (3) | 0.0597 (3) | −0.01024 (19) | 0.0070 (2) | −0.0018 (2) |
O1 | 0.0713 (9) | 0.0848 (10) | 0.0506 (8) | 0.0213 (7) | 0.0009 (7) | 0.0096 (7) |
O2 | 0.0498 (7) | 0.0681 (8) | 0.0529 (7) | 0.0183 (6) | 0.0129 (6) | 0.0081 (6) |
N1 | 0.0395 (8) | 0.0795 (11) | 0.0508 (9) | −0.0050 (7) | 0.0070 (6) | −0.0022 (8) |
C2 | 0.0455 (10) | 0.0606 (11) | 0.0475 (10) | −0.0066 (8) | 0.0064 (8) | −0.0016 (8) |
C3 | 0.0393 (9) | 0.0544 (10) | 0.0367 (8) | 0.0011 (7) | 0.0069 (7) | 0.0000 (7) |
C4 | 0.0377 (8) | 0.0548 (10) | 0.0325 (8) | −0.0016 (7) | 0.0073 (6) | −0.0002 (7) |
C5 | 0.0719 (13) | 0.0630 (12) | 0.0520 (11) | 0.0133 (10) | 0.0128 (9) | 0.0027 (9) |
C6 | 0.0980 (19) | 0.0785 (15) | 0.0680 (14) | 0.0429 (14) | 0.0143 (13) | 0.0066 (11) |
C7 | 0.0768 (16) | 0.118 (2) | 0.0564 (13) | 0.0554 (16) | 0.0110 (11) | 0.0060 (13) |
C8 | 0.0445 (11) | 0.120 (2) | 0.0476 (11) | 0.0239 (11) | 0.0085 (8) | −0.0009 (11) |
C9 | 0.0412 (9) | 0.0793 (13) | 0.0337 (9) | 0.0101 (8) | 0.0090 (7) | −0.0001 (8) |
C10 | 0.0451 (9) | 0.0608 (11) | 0.0301 (8) | 0.0100 (8) | 0.0088 (7) | 0.0016 (7) |
C11 | 0.0440 (9) | 0.0499 (9) | 0.0481 (10) | −0.0006 (7) | 0.0042 (8) | 0.0018 (8) |
C12 | 0.0544 (11) | 0.0706 (12) | 0.0778 (13) | 0.0229 (10) | 0.0136 (10) | 0.0079 (11) |
C13 | 0.0641 (14) | 0.1089 (19) | 0.0878 (16) | 0.0215 (13) | 0.0227 (12) | −0.0130 (14) |
Cl1—C2 | 1.745 (2) | C6—C7 | 1.396 (4) |
Cl2—C4 | 1.7248 (16) | C6—H6 | 0.9300 |
O1—C11 | 1.195 (2) | C7—C8 | 1.356 (4) |
O2—C11 | 1.323 (2) | C7—H7 | 0.9300 |
O2—C12 | 1.459 (2) | C8—C9 | 1.413 (3) |
N1—C2 | 1.287 (2) | C8—H8 | 0.9300 |
N1—C9 | 1.371 (3) | C9—C10 | 1.414 (2) |
C2—C3 | 1.411 (2) | C12—C13 | 1.476 (3) |
C3—C4 | 1.367 (2) | C12—H12A | 0.9700 |
C3—C11 | 1.500 (2) | C12—H12B | 0.9700 |
C4—C10 | 1.417 (2) | C13—H13A | 0.9600 |
C5—C6 | 1.360 (3) | C13—H13B | 0.9600 |
C5—C10 | 1.412 (3) | C13—H13C | 0.9600 |
C5—H5 | 0.9300 | ||
C11—O2—C12 | 116.84 (14) | C9—C8—H8 | 119.8 |
C2—N1—C9 | 117.06 (15) | N1—C9—C8 | 118.38 (18) |
N1—C2—C3 | 126.55 (18) | N1—C9—C10 | 122.85 (15) |
N1—C2—Cl1 | 116.62 (14) | C8—C9—C10 | 118.77 (19) |
C3—C2—Cl1 | 116.83 (14) | C5—C10—C9 | 119.45 (16) |
C4—C3—C2 | 116.09 (15) | C5—C10—C4 | 124.43 (17) |
C4—C3—C11 | 122.35 (14) | C9—C10—C4 | 116.12 (16) |
C2—C3—C11 | 121.55 (15) | O1—C11—O2 | 125.64 (16) |
C3—C4—C10 | 121.33 (15) | O1—C11—C3 | 123.90 (16) |
C3—C4—Cl2 | 119.25 (12) | O2—C11—C3 | 110.46 (14) |
C10—C4—Cl2 | 119.42 (13) | O2—C12—C13 | 107.24 (16) |
C6—C5—C10 | 119.7 (2) | O2—C12—H12A | 110.3 |
C6—C5—H5 | 120.2 | C13—C12—H12A | 110.3 |
C10—C5—H5 | 120.2 | O2—C12—H12B | 110.3 |
C5—C6—C7 | 121.2 (2) | C13—C12—H12B | 110.3 |
C5—C6—H6 | 119.4 | H12A—C12—H12B | 108.5 |
C7—C6—H6 | 119.4 | C12—C13—H13A | 109.5 |
C8—C7—C6 | 120.5 (2) | C12—C13—H13B | 109.5 |
C8—C7—H7 | 119.7 | H13A—C13—H13B | 109.5 |
C6—C7—H7 | 119.7 | C12—C13—H13C | 109.5 |
C7—C8—C9 | 120.4 (2) | H13A—C13—H13C | 109.5 |
C7—C8—H8 | 119.8 | H13B—C13—H13C | 109.5 |
D—H···A | D—H | H···A | D···A | D—H···A |
C7—H7···O1i | 0.93 | 2.69 | 3.586 (3) | 162 |
Symmetry code: (i) x+1, −y+3/2, z+1/2. |
D—H···A | D—H | H···A | D···A | D—H···A |
C7—H7···O1i | 0.93 | 2.69 | 3.586 (3) | 162.2 |
Symmetry code: (i) x+1, −y+3/2, z+1/2. |
Acknowledgements
We gratefully acknowledge support for this project by Consejo Nacional de Ciencia y Tecnología (CONACyT Grant 155029). AC and HR acknowledge support from CONACyT in the form of graduate scholarships.
References
Bruker (2012). APEX2 and SAINT. Bruker AXS Inc., Madison, Wisconsin, USA. Google Scholar
Hopkins, A. L., Ren, J., Milton, J., Hazen, R. J., Chan, J. H., Stuart, D. I. & Stammers, D. K. (2004). J. Med. Chem. 47, 5912–5922. Web of Science CrossRef PubMed CAS Google Scholar
Maartens, G., Celum, C. & Lewin, S. R. (2014). Lancet, 384, 258–271. Web of Science CrossRef PubMed Google Scholar
Reyes, H., Aguirre, G. & Chávez, D. (2013). Acta Cryst. E69, o1534. CSD CrossRef IUCr Journals Google Scholar
Sheldrick, G. M. (2015). Acta Cryst. C71, 3–8. Web of Science CrossRef IUCr Journals Google Scholar
This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.